Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Author Archives: MissionIR

MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Enterprise Data Monetization With IBM watsonx.ai-Powered Agents

Datavault AI (NASDAQ: DVLT), a platinum partner in IBM Partner Plus, announced the expanded commercialization of its flagship AI agents, DataScore and DataValue, now embedded with IBM watsonx.ai. Designed to turn enterprise data into financial assets, the tools aim to … Continue reading

Posted in Datavault AI Inc. DVLT | Leave a comment

MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Signs LOI to Acquire 15 Acres in Arizona for Modular AI Expansion

BluSky AI (OTC: BSAI), a leading innovator in modular AI infrastructure, signed a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts … Continue reading

Posted in BlueSky AI Inc. BSAI | Leave a comment

MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company … Continue reading

Posted in HeartBeam Inc. BEAT | Leave a comment

Newton Golf Company Inc. (NASDAQ: NWTG) Surpasses 50 PGA TOUR Professionals Using Its Shafts, Cementing Status as TOUR-Trusted Innovator

Newton Golf Company (NASDAQ: NWTG) has hit a major milestone in its mission to redefine golf shaft performance — more than 50 professionals across the PGA TOUR Champions and LPGA Tour have now used Newton shafts in competition (https://ibn.fm/5Mcdq). This … Continue reading

Posted in Newton Golf Comp. NWTG | Leave a comment

MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) to Acquire Land and 50MW Power Access for Delta Data Center Development

BluSky AI (OTC: BSAI), a modular AI infrastructure innovator, announced it has signed a non-binding letter of intent with Creekstone Energy LLC to acquire 25 acres within the Delta Data Center Development, including access to up to 50 megawatts of … Continue reading

Posted in BlueSky AI Inc. BSAI | Leave a comment

MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Receives FDA Fast Track Designation for CLD-201 in Soft Tissue Sarcoma

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted genetic medicine delivery therapies, announced that the U.S. Food and Drug Administration granted Fast Track designation to CLD-201 (SuperNova), its allogeneic adipose stem-cell loaded oncolytic virus for treating soft … Continue reading

Posted in Calidi Biotherapeutics Inc. CLDI | Leave a comment

MissionIRNewsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Completes Name and Ticker Change from Mullen Automotive

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced that its previously disclosed name change from Mullen Automotive Inc. to Bollinger Innovations, Inc. is effective as of July 28, 2025, along with its new Nasdaq stock symbol “BINI.” The company … Continue reading

Posted in Bollinger Innovations Inc. BINI | Leave a comment

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Highlights Rising Importance of Platinum in Electrical, Clean-Energy Applications

As global industries search for scalable and sustainable energy solutions, platinum has emerged as a critical component in the future of electrical applications. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), is well positioned to help meet this growing demand … Continue reading

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Appoints Dr. Lee T. Schalop to Board to Bolster AI-Driven Precision Oncology

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence and genomic data to accelerate oncology drug discovery, announced the appointment of Lee T. Schalop, MD, to its Board of Directors. Dr. Schalop, co-founder and former CEO of Oncoceutics … Continue reading

Posted in Lantern Pharma Inc. LTRN | Leave a comment

Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate

Investors looking for exposure to important biopharma innovation in underserved markets need to consider Clene (NASDAQ: CLNN). Clene and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company is focused on improving mitochondrial health and protecting neuronal … Continue reading

Posted in Clene Inc. CLNN | Leave a comment